Caribou Biosciences, Inc. (CRBU) › Operating IncomeCaribou Biosciences, Inc. (CRBU) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$34.30M2020: -$36.12M2021: -$66.98M2022: -$106.40M2023: -$116.06M2024: -$166.62M2025: -$148.34M-$148.34M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$148.34M+11.0%2024-$166.62M-43.6%2023-$116.06M-9.1%2022-$106.40M-58.9%2021-$66.98M-85.4%2020-$36.12M-5.3%2019-$34.30M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share